Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
48 studies found for:    "Malignant fibrous histiocytoma"
Show Display Options
Rank Status Study
21 Completed Genetic Study of Patients and Families With Diaphyseal Medullary Stenosis With Malignant Fibrous Histiocytoma of the Bone
Conditions: Stenosis;   Histiocytoma
Intervention:
22 Unknown  External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
Condition: Cancer
Interventions: Drug: indinavir sulfate;   Drug: ritonavir;   Radiation: radiation therapy
23 Completed Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma
Condition: Sarcoma
Intervention: Drug: temsirolimus (Torisel) plus liposomal doxorubicin (Doxil)
24 Completed PET Scan Combined With CT Scan in Predicting Response in Patients Undergoing Chemotherapy and Surgery for Soft Tissue Sarcoma
Condition: Sarcoma
Interventions: Biological: pegfilgrastim;   Drug: doxorubicin hydrochloride;   Drug: ifosfamide;   Drug: pegylated liposomal doxorubicin hydrochloride;   Procedure: conventional surgery;   Radiation: fludeoxyglucose F 18
25 Completed Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma
Condition: Sarcoma
Interventions: Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Procedure: conventional surgery;   Procedure: hyperthermia treatment;   Radiation: radiation therapy
26 Completed Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
Condition: Sarcoma
Intervention: Drug: soblidotin
27 Completed Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis
Condition: Sarcoma
Interventions: Procedure: conventional surgery;   Procedure: neoadjuvant therapy;   Radiation: radiation therapy
28 Terminated Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma
Condition: Sarcoma
Interventions: Drug: doxorubicin hydrochloride;   Drug: trabectedin;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment
29 Completed Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma
Condition: Sarcoma
Intervention: Drug: exatecan mesylate
30 Completed Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
Condition: Sarcoma
Interventions: Drug: doxorubicin hydrochloride;   Drug: ifosfamide
31 Completed Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma
Condition: Sarcoma
Interventions: Drug: imatinib mesylate;   Procedure: conventional surgery
32 Terminated
Has Results
Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma
Condition: Sarcoma
Interventions: Genetic: gene expression analysis;   Genetic: polymerase chain reaction;   Genetic: western blotting;   Procedure: neoadjuvant therapy;   Procedure: therapeutic conventional surgery;   Radiation: intensity-modulated radiation therapy
33 Completed Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma
Conditions: Endometrial Cancer;   Sarcoma
Intervention: Drug: perifosine
34 Completed Radiation Therapy in Treating Patients Who Have Undergone Surgery for Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet
Condition: Sarcoma
Interventions: Procedure: adjuvant therapy;   Radiation: radiation therapy
35 Recruiting Surgery With or Without Radiation Therapy in Treating Patients With Previously Untreated Nonmetastatic Retroperitoneal Soft Tissue Sarcoma
Condition: Sarcoma
Interventions: Procedure: therapeutic conventional surgery;   Radiation: 3-dimensional conformal radiation therapy
36 Unknown  Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma
Conditions: Endometrial Cancer;   Ovarian Cancer;   Sarcoma
Intervention: Drug: temozolomide
37 Completed Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma
Conditions: Endometrial Cancer;   Kidney Cancer;   Ovarian Cancer;   Pheochromocytoma;   Sarcoma
Interventions: Biological: filgrastim;   Drug: doxorubicin hydrochloride;   Drug: ifosfamide;   Drug: isolated perfusion;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Radiation: radiation therapy
38 Completed Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma
Conditions: Brain and Central Nervous System Tumors;   Endometrial Cancer;   Gastrointestinal Stromal Tumor;   Ovarian Cancer;   Sarcoma;   Small Intestine Cancer
Intervention: Drug: trabectedin
39 Unknown  Tissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEX
Condition: Sarcoma
Interventions: Genetic: microarray analysis;   Genetic: molecular diagnostic method;   Other: biologic sample preservation procedure
40 Completed BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors
Conditions: Breast Cancer;   Endometrial Cancer;   Head and Neck Cancer;   Melanoma (Skin);   Ovarian Cancer;   Sarcoma
Interventions: Drug: BI 2536;   Other: high performance liquid chromatography;   Other: mass spectrometry;   Other: pharmacological study

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-48) Show next page of results    Last Page
Indicates status has not been verified in more than two years